SUDARSANA CHAKRABARTI

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease HOMER GLEN, IL NPI 1104096940

General Payments — all program years on this page

$2,539.27

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 92
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $445.63 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $438.9816
Education $6.651

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $373.459
2019 $363.588
2020 $259.1110
2021 $336.8816
2022 $424.5815
2023 $336.0417
2024 $445.6317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097143887 Novo Nordisk Inc $21.85 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101391658 E.R. Squibb & Sons, L.L.C. $15.95 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101391670 E.R. Squibb & Sons, L.L.C. $20.80 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101391686 E.R. Squibb & Sons, L.L.C. $15.88 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104639977 AstraZeneca Pharmaceuticals LP $20.43 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105765084 AstraZeneca Pharmaceuticals LP $21.55 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117872525 Boehringer Ingelheim Pharmaceuticals, Inc. $21.24 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117872527 Boehringer Ingelheim Pharmaceuticals, Inc. $21.93 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120109157 Kerecis Limited $135.83 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132104165 PFIZER INC. $18.51 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135394413 Lilly USA, LLC $6.65 01/22/2024 Education Undisputed 01/23/2026 View at CMS
1135394415 Lilly USA, LLC $16.79 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135407925 Lilly USA, LLC $18.62 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135407927 Lilly USA, LLC $22.25 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135419037 Lilly USA, LLC $25.27 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135423081 Lilly USA, LLC $28.00 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135433567 Lilly USA, LLC $14.08 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.